STAT3 and STAT5 are two related transcription factors involved in normal mammary gland development and function. However, inappropriate activation of either STAT3 or STAT5 has been shown to play a role in breast cancer, where STAT3 is highly associated with aggressive tumors and STAT5 is associated with lower-grade and more differentiated tumors. As transcription factors, STAT3 and STAT5 transcriptionally regulate genes involved in proliferation, migration, and chemoresistance. Furthermore, STAT3 and STAT5 transcriptional activity can be modulated by several known cofactors, where these cofactors can influence how STAT3 and STAT5 interact with DNA and with other proteins, ultimately affecting transcriptional function. Interestingly, STAT3 and STAT5 share a subset of overlapping target genes and can compete for DNA binding of shared binding sites. These STATs have also been shown to have opposing effects on overlapping target gene expression, where gene expression is determined by the STAT protein occupying the promoter. This is particularly interesting since STAT5-driven breast tumors are molecularly distinct from STAT3-driven breast tumors. Furthermore, concurrent activation of STAT3 and STAT5 is associated with more favorable tumor types compared to tumors with activated STAT3 alone, suggesting that the relationship between these two STATs is critical. Developing a better understanding about the roles that STAT3 and STAT5 play in breast cancer will be important for successful treatment in the future.
STAT3与STAT5是两种相关的转录因子，参与正常乳腺的发育与功能调控。然而，这两种因子的异常激活均被证实与乳腺癌的发生发展相关：STAT3与侵袭性肿瘤高度相关，而STAT5则与低级别、高分化肿瘤相关。作为转录因子，STAT3和STAT5通过转录调控参与细胞增殖、迁移及化疗耐药的相关基因。此外，多种已知辅助因子可调节STAT3与STAT5的转录活性，这些辅助因子能影响STAT蛋白与DNA及其他蛋白质的相互作用，最终调控转录功能。值得注意的是，STAT3与STAT5共享部分重叠靶基因，并可能竞争结合相同的DNA位点。研究显示这两种STAT蛋白对重叠靶基因的表达具有拮抗效应，其表达水平取决于占据启动子区域的STAT蛋白类型。这一现象尤其值得关注，因为STAT5驱动的乳腺肿瘤在分子特征上与STAT3驱动的肿瘤存在显著差异。此外，与仅激活STAT3的肿瘤相比，STAT3与STAT5同时激活的肿瘤往往预后更佳，这表明两者间的相互作用关系至关重要。深入理解STAT3和STAT5在乳腺癌中的作用机制，将为未来制定有效治疗策略提供重要依据。
肿瘤(癌症)患者之家